Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Canada House Wellness Group (CHV) subsidiary Abba Medix has made a supply deal with the BC Liquor Distribution Branch. 
  • Abba will be now able to offer customers recreational products in 3.5g dried flower and 0.5g pre-rolled formats in British Columbia.
  • This is the second provincial supply agreement that Abba has announced this week.
  • Canada House’s share price remains unchanged, with shares trading at $0.03 apiece.

Canada House Wellness Group (CHV) subsidiary, Abba Medix, has entered into another supply agreement deal, this time with the BC Liquor Distribution Branch.

This is the second announcement of the sort for Abba this week, with the company revealing a similar supply agreement with Alberta Gaming, Liquor, and Cannabis (AGLC) just yesterday.

Through the new supply agreement, Abba will initially be able to offer BC customers recreational use products in 3.5g dried flower and 0.5g pre-rolled formats. 

The BC Liquor Distribution Branch is the only wholesale distributor of non-medical cannabis in British Columbia.

Abba President and Chief Revenue Officer of Canada House, Michael Orrbrooke, spoke about the new BC supply agreement. “The addition of another provincial partner is a great milestone for Abba. We have been working hard to grow our distribution through strong relationships with targeted provinces across the country.”

Canada House’s share price remains unchanged, with shares trading at $0.03 apiece.

More From The Market Herald

" 1CM Inc. (CSE:EPIC) announces Uber Eats cannabis delivery listing

1CM (EPIC) subsidiary, Tirthankar Ltd, will provide cannabis delivery on the Uber Eats platform.

" Luff Enterprises (CSE:LUFF) provides business update

Luff Enterprises (LUFF) has provided an update on its marketplace rollout.
The Market Herald Video

" Tetra Bio-Pharma (TSX:TBP) provides update on patent applications for Novel Therapeutic ARDS-003

Tetra Bio-Pharma (TBP) has filed three patent applications for its novel therapeutic, ARDS-003.

" HYTN (CSE:HYTN) sells out of innovative holiday products

HYTN’s (HYTN) wholly owned subsidiary, HYTN Cannabis Inc., has achieved 100 per cent purchase fulfillment of its holiday offerings.